---
figid: PMC5047222__peerj-04-2348-g001
figtitle: 'Formal modeling and analysis of the hexosamine biosynthetic pathway: role
  of O-linked N-acetylglucosamine transferase in oncogenesis and cancer progression'
organisms:
- NA
pmcid: PMC5047222
filename: peerj-04-2348-g001.jpg
figlink: /pmc/articles/PMC5047222/figure/fig-1/
number: F1
caption: The HBP (right) generates Uridine diphosphate N-acetylglucosamine (UDP-GlcNAc)
  as the end product that is used by the O-GlcNAc transferase (OGT) to covalently
  attach O-GlcNAc to hydroxyl groups of serine/threonine residues of proteins. This
  dynamic process is antagonized by O-GlcNAcase (OGA). In cancer, increased HBP flux
  leads to hyper O-GlcNAcylation. Hyper O-GlcNAcylation of c-Myc activates the phosphoinositide
  3-kinase (PI3K)-mTOR-MYC signaling axis (middle). The PI3K pathway cross-talks with
  Forkhead box M1 (FoxM1), an oncogenic transcription factor that is regulated by
  levels of O-GlcNAc and OGT (middle). Inflammatory responses to genotoxic stress
  induce activation of NF-κB that can undergo O-GlcNAcylation to mediate genes in
  the immune response (left). The loss of p53 activates NF-κB to increase aerobic
  glycolysis and support tumor metabolism. Hyper O-GlcNAcylation of p53 stabilizes
  the tumor suppressor and decreases p53-MDM2 interaction to block proteolysis (bottom).
  In response to stress, p53 can induce cyclin-dependent kinase inhibitor p21 to inhibit
  proliferation.
papertitle: 'Formal modeling and analysis of the hexosamine biosynthetic pathway:
  role of O-linked N-acetylglucosamine transferase in oncogenesis and cancer progression.'
reftext: Muhammad Tariq Saeed, et al. PeerJ. 2016;4:e2348.
year: '2016'
doi: .na.character
journal_title: .na.character
journal_nlm_ta: .na.character
publisher_name: .na.character
keywords: .na.character
automl_pathway: 0.9171557
figid_alias: PMC5047222__F1
figtype: Figure
organisms_ner:
- Homo sapiens
redirect_from: /figures/PMC5047222__F1
ndex: 756de036-df0f-11ea-99da-0ac135e8bacf
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC5047222__peerj-04-2348-g001.html
  '@type': Dataset
  description: The HBP (right) generates Uridine diphosphate N-acetylglucosamine (UDP-GlcNAc)
    as the end product that is used by the O-GlcNAc transferase (OGT) to covalently
    attach O-GlcNAc to hydroxyl groups of serine/threonine residues of proteins. This
    dynamic process is antagonized by O-GlcNAcase (OGA). In cancer, increased HBP
    flux leads to hyper O-GlcNAcylation. Hyper O-GlcNAcylation of c-Myc activates
    the phosphoinositide 3-kinase (PI3K)-mTOR-MYC signaling axis (middle). The PI3K
    pathway cross-talks with Forkhead box M1 (FoxM1), an oncogenic transcription factor
    that is regulated by levels of O-GlcNAc and OGT (middle). Inflammatory responses
    to genotoxic stress induce activation of NF-κB that can undergo O-GlcNAcylation
    to mediate genes in the immune response (left). The loss of p53 activates NF-κB
    to increase aerobic glycolysis and support tumor metabolism. Hyper O-GlcNAcylation
    of p53 stabilizes the tumor suppressor and decreases p53-MDM2 interaction to block
    proteolysis (bottom). In response to stress, p53 can induce cyclin-dependent kinase
    inhibitor p21 to inhibit proliferation.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - ITGA1
  - ITGA10
  - ITGA11
  - ITGA2
  - ITGA2B
  - ITGA3
  - ITGA4
  - ITGA5
  - ITGA6
  - ITGA7
  - ITGA8
  - ITGA9
  - ITGAD
  - ITGAE
  - ITGAL
  - ITGAM
  - ITGAV
  - ITGAX
  - ITGB1
  - ITGB2
  - ITGB3
  - ITGB4
  - ITGB5
  - ITGB6
  - ITGB7
  - ITGB8
  - ITGBL1
  - CD19
  - PTK2
  - PIK3CA
  - PIK3CB
  - PIK3CD
  - PIK3CG
  - PIK3R3
  - PIK3R4
  - PIK3R5
  - PIK3R6
  - PIK3R1
  - PIK3R2
  - GAB1
  - PIGU
  - JAK1
  - ILK
  - RS1
  - RSC1A1
  - IRS1
  - GAB2
  - OGT
  - EOGT
  - POMGNT1
  - POMGNT2
  - MYC
  - OGA
  - PDK1
  - PDPK1
  - FOXM1
  - AKT1
  - AKT2
  - AKT3
  - FOXO3
  - MAP3K8
  - CHUK
  - NFKB1
  - RELA
  - RELB
  - REL
  - NFKB2
  - E2F1
  - E2F2
  - E2F3
  - E2F4
  - E2F5
  - E2F6
  - E2F7
  - E2F8
  - MDM2
  - CDKN1A
  - TP53
  - TP63
  - TP73
  - UDP
  - Cancer
---
